drugset / Trial / NCT00324142

A Pilot Study of Oral Tinidazole for Women With Recurrent Bacterial Vaginosis

NCT00324142

Phase 2 Withdrawn Kaiser Permanente
RandomizedParallel-groupOpen-labelTreatment

Summary

This is a study of the drug tinidazole for women with recurrent bacterial vaginosis. Half of the participants will get the drug for 10 days, the other half will get the drug for 10 days and then twice a week for 12 weeks.

Timeline

Start
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject tinidazole Small molecule Oral

Indications